Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BELDEN INC. Director's Dealing 2012

Feb 14, 2012

31053_dirs_2012-02-14_3a5c6867-690c-44a1-8cc8-79bf99578eab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BELDEN INC. (BDC)
CIK: 0000913142
Period of Report: 2012-02-10

Reporting Person: Benoist Gray G (SVP Finance and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-10 Common Stock M 34667 $11.92 Acquired 67596 Direct
2012-02-10 Common Stock D 18465 $39.01 Disposed 49131 Direct
2012-02-10 Common Stock M 16817 $21.70 Acquired 65948 Direct
2012-02-10 Common Stock D 12367 $39.01 Disposed 53581 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-10 Stock Appreciation Rights $11.92 M 34667 Disposed 2019-02-24 Common Stock (34667) Direct
2012-02-10 Stock Appreciation Rights $21.70 M 16817 Disposed 2020-02-22 Common Stock (16817) Direct

Footnotes

F1: This represents the difference between the number of SARs exercised (34,667) and the number of shares issued as a result of the exercise (16,202). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($39.01) and the exercise price ($11.92). Additional shares are then withheld to satisfy the Company's tax withholding obligations.

F2: This represents the difference between the number of SARs exercised (16,817) and the number of shares issued as a result of the exercise (4,450). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($39.01) and the exercise price ($21.70). Additional shares are then withheld to satisfy the Company's tax withholding obligations.

F3: 17,334 SARs became exercisable on February 24, 2010 and 17,333 SARs became exercisable on February 24, 2011. The remaining 17,333 SARs will become exercisable on February 24, 2012.

F4: 16,817 SARs became exercisable on February 22, 2011. The remaining 33,632 SARs are scheduled to become exercisable in equal installments on February 22, 2012 and February 22, 2013.